Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 6—December 2001

Research

The Serologic Response to Cryptosporidium in HIV-Infected Persons: Implications for Epidemiologic Research

Joseph N.S. Eisenberg*Comments to Author , Jeffrey W. Priest†, Patrick J. Lammie†, and John M. Colford*
Author affiliations: *University of California, Berkeley, California, USA;; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Summary of antibody responses for the 11 cases and their respective controls

Cases Controls Cases Controls Cases Controls Cases Controls
Mean 2,784c 414 2,117c -17 1,594 85 1,531 5
Max 12,224 973 11,247 157 9,264 217 9,239 69
Min 102 178 -866 -144 36 41 -5 47
Median 1,334d 329 433d -32 140 56 71d 1
S.D. 3,560 237 3,531 84 2,880 53 2,884 36
N 11 22 11 22 11 22 11 22

aIgG response after the date of clinical cryptosporidiosis diagnosis.
bDifference in IgG response between a sample taken before and after date of cryptosporidiosis diagnosis.
cCase value is significantly different from control value (p<0.05).
dCase value is significantly different from control value (p<0.01).
IgG = immunoglobulin G; TX17 = Triton antigen; SD = standard deviation.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO